Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$21.19 - $31.29 $26,741 - $39,487
-1,262 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$29.29 - $36.87 $3,661 - $4,608
-125 Reduced 9.01%
1,262 $42,000
Q2 2018

Aug 03, 2018

SELL
$28.9 - $37.31 $3,612 - $4,663
-125 Reduced 8.27%
1,387 $49,000
Q1 2018

May 02, 2018

BUY
$26.78 - $39.35 $34,599 - $50,840
1,292 Added 587.27%
1,512 $49,000
Q4 2017

Feb 05, 2018

BUY
$21.56 - $28.14 $4,743 - $6,190
220
220 $6,000

Others Institutions Holding ALBO

About ALBIREO PHARMA, INC.


  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.